Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Freitag

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 16, 2025
First-in-Human PET Imaging of MT1-MMP in a Patient with Breast and Muscle-Invasive Urothelial Bladder Cancer Using the Bicyclic Radiotracer [<sup>68</sup>Ga]Ga-BCY25286Ann-Christin Eder, Mohamed Aymen Omrane, Mohamed El Fakiri, et al.
Scientific Reports|October 30, 2024
A student trained convolutional neural network competing with a commercial AI software and experts in organ at risk segmentationSophia L Bürkle, Dejan Kuhn, Tobias Fechter, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 10, 2026
First-in-human EphA2-targeting PET imaging with the bicyclic radiotracer [<sup>68</sup>Ga]Ga-BCY18469 in pancreatic cancer patients: biodistribution, dosimetry and initial findingsAnn-Christin Eder, Christoph-Ferdinand Wielenberg, Mohamed Aymen Omrane, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|December 22, 2017
Integration of CT urography improves diagnostic confidence of <sup>68</sup>Ga-PSMA-11 PET/CT in prostate cancer patientsLeon Will, Frederik L Giesel, Martin T Freitag, et al.
Journal of Endourology|July 9, 2015
The Impact of Magnetic Resonance Imaging on Prediction of Extraprostatic Extension and Prostatectomy Outcome in Patients with Low-, Intermediate- and High-Risk Prostate Cancer: Try to Find a StandardJan Philipp Radtke, Boris A Hadaschik, Maya B Wolf, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 18, 2017
Simultaneous whole-body <sup>18</sup>F-PSMA-1007-PET/MRI with integrated high-resolution multiparametric imaging of the prostatic fossa for comprehensive oncological staging of patients with prostate cancer: a pilot studyMartin T Freitag, Claudia Kesch, Jens Cardinale, et al.
European Journal of Radiology|November 7, 2017
Improved clinical workflow for simultaneous whole-body PET/MRI using high-resolution CAIPIRINHA-accelerated MR-based attenuation correctionMartin T Freitag, Matthias Fenchel, Philipp Bäumer, et al.
Prostate Cancer and Prostatic Diseases|May 18, 2016
Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillanceJ P Radtke, T H Kuru, D Bonekamp, et al.
Journal of Magnetic Resonance Imaging : JMRI|July 16, 2016
In vivo assessment of cold stimulation effects on the fat fraction of brown adipose tissue using DIXON MRIVanessa Stahl, Florian Maier, Martin T Freitag, et al.
Theranostics|April 22, 2024
Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [<sup>177</sup>Lu]Lu-PSMA-617 for prostate cancer - from bench to bedsideDaria Arbuznikova, Aikaterini Klotsotyra, Lisa Uhlmann, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 16, 2025
First-in-Human PET Imaging of MT1-MMP in a Patient with Breast and Muscle-Invasive Urothelial Bladder Cancer Using the Bicyclic Radiotracer [<sup>68</sup>Ga]Ga-BCY25286Ann-Christin Eder, Mohamed Aymen Omrane, Mohamed El Fakiri, et al.
Scientific Reports|October 30, 2024
A student trained convolutional neural network competing with a commercial AI software and experts in organ at risk segmentationSophia L Bürkle, Dejan Kuhn, Tobias Fechter, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 10, 2026
First-in-human EphA2-targeting PET imaging with the bicyclic radiotracer [<sup>68</sup>Ga]Ga-BCY18469 in pancreatic cancer patients: biodistribution, dosimetry and initial findingsAnn-Christin Eder, Christoph-Ferdinand Wielenberg, Mohamed Aymen Omrane, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|December 22, 2017
Integration of CT urography improves diagnostic confidence of <sup>68</sup>Ga-PSMA-11 PET/CT in prostate cancer patientsLeon Will, Frederik L Giesel, Martin T Freitag, et al.
Journal of Endourology|July 9, 2015
The Impact of Magnetic Resonance Imaging on Prediction of Extraprostatic Extension and Prostatectomy Outcome in Patients with Low-, Intermediate- and High-Risk Prostate Cancer: Try to Find a StandardJan Philipp Radtke, Boris A Hadaschik, Maya B Wolf, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 18, 2017
Simultaneous whole-body <sup>18</sup>F-PSMA-1007-PET/MRI with integrated high-resolution multiparametric imaging of the prostatic fossa for comprehensive oncological staging of patients with prostate cancer: a pilot studyMartin T Freitag, Claudia Kesch, Jens Cardinale, et al.
European Journal of Radiology|November 7, 2017
Improved clinical workflow for simultaneous whole-body PET/MRI using high-resolution CAIPIRINHA-accelerated MR-based attenuation correctionMartin T Freitag, Matthias Fenchel, Philipp Bäumer, et al.
Prostate Cancer and Prostatic Diseases|May 18, 2016
Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillanceJ P Radtke, T H Kuru, D Bonekamp, et al.
Journal of Magnetic Resonance Imaging : JMRI|July 16, 2016
In vivo assessment of cold stimulation effects on the fat fraction of brown adipose tissue using DIXON MRIVanessa Stahl, Florian Maier, Martin T Freitag, et al.
Theranostics|April 22, 2024
Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [<sup>177</sup>Lu]Lu-PSMA-617 for prostate cancer - from bench to bedsideDaria Arbuznikova, Aikaterini Klotsotyra, Lisa Uhlmann, et al.
Pageof 6